Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00847821 · ClinicalTrials.gov registry record
Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene
A clinical trial, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Terminated
- Registry status
- 185
- Enrollment target
NCT00847821: Clinical Trial study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
NCT00847821 is a clinical trial that was terminated before completion, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 185 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00847821 was terminated before completion, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- TERMINATED
- Registry status
- 185 participants
- Enrollment target
Study Summary
This study is an observational study analyzing the biopsy samples collected from subjects that participated in Study 3115A1-303 (NCT00675688). These endometrial biopsy samples will be de-identified at an anatomical laboratory and then sent to a molecular biology lab where an RNA extraction and analysis will be performed. The purpose of this study is to compare specific endometrial gene regulation at the level of mRNA expression in samples from placebo, bazedoxifene/conjugated estrogens, and raloxifene treated groups with a known set of genes that have been previously identified to be associated with estrogenization, endometrial hyperplasia, and endometrial cancer.
Interventions
- DRUG Bazedoxifene 10 mg/CE 0.625 mg
- DRUG Bazedoxifene 20 mg/CE 0.625 mg
- DRUG Bazedoxifene 40 mg/CE 0.625 mg
- DRUG Bazedoxifene 10 mg/CE 0.45 mg
- DRUG Bazedoxifene 20 mg/CE 0.45 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-08 |
Why NCT00847821 stopped before completion
NCT00847821 is an observational study that tracks outcomes without assigning an intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Bazedoxifene 10 mg/CE 0.625 mg is the first listed.
NCT00847821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00847821 about?
NCT00847821 is a clinical study titled "Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene". This study is an observational study analyzing the biopsy samples collected from subjects that participated in Study 3115A1-303 (NCT00675688). These endometrial biopsy samples will be de-identified at an anatomical laboratory and then sent to a molecular biology lab where an RNA extraction and analy...
What is the current status of trial NCT00847821?
This trial is currently terminated. The enrollment target is 185 participants. The study started on 2009-05. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00847821?
The interventions under investigation include: Bazedoxifene 10 mg/CE 0.625 mg (DRUG), Bazedoxifene 20 mg/CE 0.625 mg (DRUG), Bazedoxifene 40 mg/CE 0.625 mg (DRUG), Bazedoxifene 10 mg/CE 0.45 mg (DRUG), Bazedoxifene 20 mg/CE 0.45 mg (DRUG).
Who is sponsoring clinical trial NCT00847821?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia